Related Experiment Video
Updated: Jan 21, 2026
13:27
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
49.0K
Mycobacterium tuberculosis-Associated Necrotizing Pneumonia With Adjunctive Corticosteroid Therapy
Ho Lam Nguyen1, Huyen Duong Thanh1, Thuong Vu Le1,2
1Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Case Reports in Infectious Diseases
|July 30, 2019
Summary
Necrotizing pneumonia caused by Mycobacterium tuberculosis is rare and hard to diagnose. This case highlights successful treatment using corticosteroids alongside standard antituberculosis drugs.
Area of Science:
- Pulmonology
- Infectious Diseases
- Microbiology
Background:
- Necrotizing pneumonia is a severe lung infection.
- Distinguishing Mycobacterium tuberculosis (M. tuberculosis)-induced pneumonia from bacterial pneumonia is challenging.
- Optimal treatment strategies for M. tuberculosis-associated necrotizing pneumonia remain debated.
Observation:
- A rare case of necrotizing pneumonia was caused by M. tuberculosis.
- The patient presented with symptoms that made differentiation from bacterial pneumonia difficult.
Findings:
- The patient received a combination of antituberculosis drugs and adjunctive corticosteroids.
- This treatment regimen was effective in managing the M. tuberculosis-associated necrotizing pneumonia.
Implications:
- Corticosteroids may be a beneficial adjunctive therapy for M. tuberculosis-associated necrotizing pneumonia.
- This case contributes to understanding treatment options for this rare condition.
- Further research is warranted to confirm the efficacy of corticosteroids in similar cases.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
277
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
01:26COPD: Management Using Bronchodilators and Corticosteroids
748
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
748
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
01:30Pneumonia I: Introduction
772
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
772
01:29Pneumonia II: Pathophysiology
2.7K
The pathophysiology of pneumonia involves the following steps:
2.7K
01:29Pulmonary Tuberculosis I
869
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
869